Skip to content
Beam Therapeutics

Submit your resume for future Manufacturing and Quality roles located in RTP, NC

Durham, NCUnited States
Future RTP North Carolina Openings
POSTED 14 OCT 2022
Apply Ask
Role
1487 days opentrue age
Posted 14 Oct 2022
Pay
$58k–$61kno pay posted
$51k$110k
Market p25–p75
$51k–$110k
Beam Therapeutics p25–p75
$58k–$61kn=4
Raleigh-Durham · n=137 · 365d to 6 Nov
CompanyBeam Therapeutics →
40open roles
Opened · 30d
+1
Closed · 30d
−3
6d of snapshots · 30d window
Market
416,799open · Other
Opened · 7d
+21,4475% of open
All other
624,315open
All tracked boards · live 10 Nov · n=416,799

Company Overview

Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform with integrated gene editing, delivery and internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.

Beam is preparing to open a state-of-the-art Manufacturing facility located on Davis Drive in RTP, NC and will be looking for Manufacturing and Quality professionals to join our team! Please submit your resume here to be considered for positions that we will be opening in Q4 2022 and throughout 2023. We are looking for fearless innovators who are passionate about helping patients and looking to join a collaborative environment where you will be able to have a direct impact on getting our facility up and running.

Source · Beam TherapeuticsFirst seen 4 NovOriginal ↗